SunCoke Energy (SXC) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
28 Nov, 2025Executive summary
Q1 2025 Adjusted EBITDA was $59.8 million, down from $67.9 million in Q1 2024, with EPS at $0.20, a decrease of $0.03 year-over-year, as strong logistics performance partially offset weaker domestic coke results due to challenging spot market and lower Granite City contract economics.
Extended Granite City contract with U.S. Steel through September 30, 2025, with an option for an additional three months, at lower economics and volumes.
Declared a $0.12 per share dividend, payable June 2, 2025.
Ended Q1 with $543.7 million in liquidity, including $193.7 million cash and $350 million undrawn revolver; gross leverage at 1.89x trailing 12-month Adjusted EBITDA.
Financial highlights
Q1 2025 sales and other operating revenue: $436.0 million, down from $488.4 million in Q1 2024.
Net income attributable to shareholders was $17.3 million, or $0.20 per share, down from $20.0 million, or $0.23 per share, year-over-year.
Domestic Coke Adjusted EBITDA was $49.9 million on sales of 898,000 tons; Logistics Adjusted EBITDA was $13.7 million on 5.724 million tons handled.
Operating income for Q1 2025 was $30.2 million, down from $34.5 million year-over-year.
Net cash provided by operating activities was $25.8 million, up from $10.0 million in Q1 2024.
Outlook and guidance
Reaffirmed full-year 2025 consolidated Adjusted EBITDA guidance of $210–$225 million and Free Cash Flow of $100–$115 million.
Domestic Coke Adjusted EBITDA guidance: $185–$192 million; Logistics Adjusted EBITDA: $45–$50 million.
Domestic Coke total production forecasted at approximately 4.0 million tons; CapEx guidance at $65 million.
Full-year operating cash flow guidance unchanged at $165–$180 million.
Latest events from SunCoke Energy
- 2026 outlook projects EBITDA and FCF growth after a challenging 2025 with one-time impacts.SXC
Q4 202517 Feb 2026 - Q3 adjusted EBITDA hit $75.3M, net income rose, and 2024 guidance was raised on regulatory gain.SXC
Q3 202413 Feb 2026 - Q2 Adjusted EBITDA hit $63.5M, with a 20% dividend hike and strong full-year outlook.SXC
Q2 20242 Feb 2026 - 2024 Adjusted EBITDA exceeded guidance; 2025 faces margin pressure but strong liquidity persists.SXC
Q4 20249 Jan 2026 - 2025 meeting to vote on directors, pay, and auditor amid strong results and robust governance.SXC
Proxy Filing1 Dec 2025 - Virtual meeting to elect directors, approve pay, and ratify auditor on May 15, 2025.SXC
Proxy Filing1 Dec 2025 - $325M acquisition expands reach, diversifies earnings, and delivers immediate accretion and synergies.SXC
M&A Announcement25 Nov 2025 - Q2 2025 earnings fell, but liquidity is strong and a $325M acquisition closes August 1.SXC
Q2 202516 Nov 2025 - Q3 2025 Adjusted EBITDA dropped to $59.1M, with FY guidance cut to $220–$225M after a contract breach.SXC
Q3 202513 Nov 2025